This Oct. 10, 2013 file photo shows an EpiPen epinephrine auto-injector, a Mylan product, in Hendersonville, Texas. (AP Photo/Mark Zaleski, File) NEW YORK • Dutch drugmaker Mylan says it will launch a ...
Viatris’ (NASDAQ:VTRS) Mylan unit is no longer a subject of DOJ’s antitrust investigation in the generic drug industry, the pharmaceutical firm said on Tuesday. In 2017, Mylan’s former president and ...
The generic drug maker's stock climbs by more than 16 percent. Wall Street investors reacted favorably to Teva Pharmaceutical Industries’ decision to abandon its hostile takeover attempt for Mylan NV ...
Bloomfield, Conn.-based Cigna dropped coverage for Mylan’s EpiPen and EpiPen Jr. auto-injectors in favor of its generic alternative according to the payer’s prescription drug list changes, which were ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results